An investigational medication is what is being studied to see if symptoms improve while taking it. It is not yet approved for general use by regulatory authorities. This study uses an investigational medication called Riliprubart. The investigational medicine is injected in a vein or under the skin, either at the …
This study investigates the effectiveness and safety of an investigational medication compared to a placebo in treating Systemic Lupus Erythematosus (SLE). Participants in this study will be adults aged 18 to 70 years who have active SLE.Participants will be randomly assigned to one of two study arms: one receiving the …
This study investigates the effects of an investigational medication in adults with non-responsive celiac disease (NRCD) who follow a gluten-free diet. This study aims to understand how the investigational medication affects intestinal damage caused by gluten exposure, as measured by the villous height to crypt depth ratio, and its impact …
This study investigates the efficacy and safety of an investigational medication in adults with moderate to severe Crohn's Disease (CD). This study compares different doses of the investigational medication with a placebo to determine its effectiveness in managing CD symptoms.Participants will undergo various study procedures, including a Double-Blind (DB) treatment …
This study investigates the effects of an investigational medication compared to a placebo in adults aged 18 and older with warm autoimmune hemolytic anemia (wAIHA). The study aims to assess the effectiveness and safety of the investigational medication in achieving a durable hemoglobin response, which is a measure of the …
This study investigates the effects of an investigational medication compared to a daily oral dose of another treatment in adults with relapsing forms of multiple sclerosis (RMS). This study aims to measure the annualized relapse rate (ARR) in participants aged 18 to 55 who have been diagnosed with RMS.Participants will …
This study investigates the effects of an investigational medication compared with a placebo in adults with high-risk asthma. This study involves adults aged 18 to 80 years who have asthma but are not eligible for biologic treatments.Participants will receive either the investigational medication or a placebo, which is an inactive …
This study investigates the effects of an investigational medication compared to a placebo in adults and adolescents with newly diagnosed Type 1 diabetes (T1D) who are already on insulin therapy. Participants will be randomly assigned to receive one of three different doses of the investigational medication or a placebo, which …
This study investigates the effectiveness and safety of an investigational medication compared to a placebo in treating chronic lung allograft dysfunction (CLAD) in adults who have had a lung transplant. Participants in this study must have had their transplant at least a year ago and must be experiencing progression of …
This study investigates the safety and immune response of an investigational vaccine for meningococcal disease in children under 10 years old. The purpose of this study is to evaluate two formulations of the investigational vaccine, comparing them to existing vaccines. The study is conducted in three stages: Stage 1 involves …
